Environmental typology of rivers from the Brazilian semiarid as a first step for the application of the index of biotic integrity: The case of the Chapada Diamantina

Defining environmental river types is an essential step in the development of accurate fish‐based methods (IBI, Index of Biotic Integrity) to assess the environmental quality of aquatic ecosystems. In this study, the environmental typology of the rivers and streams in the region of Chapada Diamantina was developed. Thirty‐five sampling sites representative of the upper Paraguaçu River and its main tributaries were characterized to characterize the fish assemblages and abiotic environmental descriptors. A cluster analysis based on fish species CPUE was performed to define a first biological typology. Then, a discriminant analysis model was developed to select the environmental descriptors that explained the fish‐based river types. The model selected 11 environmental variables and classified 91% of the cases. The river typology defined in this study will be used for the development of an IBI to assess the ecological status of the Chapada Diamantina rivers. It is expected that both the typology developed here and the future IBI will provide important and useful tools to develop and apply nature conservation‐oriented management schemes in the Chapada Diamantina aquatic ecosystems.info:eu-repo/semantics/acceptedVersio

Linking fish-based biological indicators with hydrological dynamics in a Mediterranean river: Relevance for environmental flow regimes

The relationship between flow dynamics and biological communities becomes especially relevant in Mediterranean rivers. Given their natural variability and growing anthropogenic pressures, their low sections are subjected to multiple impacts. The definition of ecohydrological relationships in Mediterranean rivers may constitute a useful management tool. Historically, fishes were the first group used to assess community-level ecological quality, and different indices and metrics have been proposed. However, up to date many of these indicators have showed to be insensitive to flow regime changes or hydrological alteration. There is therefore a need to deepen into the ecohydrological relationships between such indicators and flow regimes in Mediterranean (and other) rivers. This study presents an analysis of the relationship between interannual flow regimes in the lower section of the Ebro River, defined using a set of daily and hourly hydrological indices, and ecological quality based on fish community, assessed through indices designed to fulfill the Water Framework Directive (WFD) in Europe: the Indices of Biotic Integrity in Catalan rivers (IBICAT2010 and IBICAT2b) and the new European Fish Index (EFI+). In order to identify spatiotemporal patterns, hydrological indices were computed using time periods of different amplitude and ecological quality was obtained in different transects along the river section, even within the same water units or ‘water masses’ (subdivisions of surface waters to fulfill the WFD in Spain). Our results showed that IBICAT2010 was the most correlated with hydrological indices, followed by IBICAT2b and EFI+. The latter showed an almost null correlation with hydrological indices, which may be due to issues associated with the sampling technique, the definition of transects and because it does not uses stream typologies. Correlations among some hydrological and biological indices were observed, with temporal and spatial patterns. On one hand, daily hydrological indices showed relationship with ecological quality when they were computed using between 9 and 36 months of flow records (previous to the sampling date) whereas subdaily indices responded better to periods between 3 and 9 months of records. On the other hand, some sampling transects showed clearer relationships than others, even within the same water mass, which suggests an influence of hydromorphological variability on the obtained ecological quality scores.info:eu-repo/semantics/acceptedVersio

Basin-scale land use impacts on world deltas: Human vs natural forcings

A new global database of 86 deltas and river basins was analyzed to investigate the relative importance of deforestation and land use changes versus natural forcings in determining long-term total delta size. Results show that mean river flow and shelf slope were the most important variables, whereas population density and sediment load had a much lower importance. Deforestation and other variables related to land-use generally had a very small effect, but were more influential in a subset comprising Mediterranean and Black Sea deltas. As most deltas have developed over thousands of years, the much shorter-lived anthropogenic signals from deforestation and other landscape perturbations have had only secondary impact on the total area of deltas. Also, delta progradation is strongly influenced on sand deposition, whereas anthropogenic impacts on sediment load have more often impacted mostly the finer sediment being deposited offshore (prodelta deposits) or in the deltaic plain. These data disproves the hypothesis that delta size and growth is strongly influenced by human forcings, particularly for larger deltas, since Holocene delta building is mainly determined by natural forces. However, humans are influencing the geomorphology of deltas, particularly over the last century when the Anthropocene nature of deltas has become manifest. A more precise terminology is proposed to clarify concepts such as “human-made”, “human-engineered” or “human-influenced” deltas.info:eu-repo/semantics/acceptedVersio

Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy

Background: Platinum-based therapy, combined or not with immune checkpoint inhibitors, represents a front-line choice for patients with non-small-cell lung cancer (NSCLC). Despite the improved outcomes in the last years for this malignancy, only a sub-group of patients have long-term benefit. Excision repair cross-complementation group 1 (ERCC1) has been considered a potential biomarker to predict the outcome of platinum-based chemotherapy in NSCLC. However, the ERCC1 gene is transcribed in four splice variants where the isoform 202 was described as the only one active and able to complex Xeroderma pigmentosum group F-complementing protein (XPF). Here, we prospectively investigated if the active form of ERCC1, as assessed by the ERCC1/XPF complex (ERCC1/XPF), could predict the sensitivity to platinum compounds.Patients and methods: Prospectively enrolled, patients with advanced NSCLC treated with a first-line regimen containing platinum were centrally evaluated for ERCC1/XPF by a proximity ligation assay. Overall survival (OS), progression-free survival (PFS) and objective response rate (ORR) were analyzed.Results: The absence of the ERCC1/XPF in the tumor suggested a trend of worst outcomes in terms of both OS [hazard ratio (HR) 1.41, 95% confidence interval (CI) 0.67-2.94, P 0.373] and PFS (HR 1.61, 95% CI 0.88-3.03, P = 0.123). ORR was marginally influenced in ERCC1/XPF-negative and -positive groups [odds ratio (stable disease progressive disease versus complete response partial response) 0.87, 95% a 0.25-3.07, P = 0.832].Conclusion: The lack of ERCC1/XPF complex in NSCLC tumor cells might delineate a group of patients with poor outcomes when treated with platinum compounds. ERCC1/XPF absence might well identify patients for whom a different therapeutic approach could be necessary

Adaptive Challenges, Adaptive Work, and Adaptive Leadership Among Women Living With HIV in the Southern United States: Findings From a Qualitative Study

Women living with HIV have a higher burden of non-AIDS comorbidities and prevalence of chronic conditions. The Adaptive Leadership Framework for Chronic Illness clarifies living with complex health challenges by delineating the technical work of health care providers as well as the adaptive work and leadership behaviors of patients and their providers. We conducted a descriptive, qualitative study of women residing in the Southern United States who were participating in the Women's Interagency HIV Study in North Carolina. Twenty-two participants (mean age = 52.2 years; 90.9% self-identifying as Black or African American) completed semi-structured qualitative interviews. We identified adaptive challenges (e.g., affective and disclosure challenges) and adaptive work and leadership behaviors. Women learned skills to care for their health and support their families and to work with their providers to manage their care. Findings support the importance of identifying leadership behaviors for the purpose of developing person-centered interventions

Exploring Resilience among Black Women Living with HIV in the Southern United States: Findings from a Qualitative Study

Black women living with HIV (WLWH) face individual and sociostructural challenges. Despite these challenges, many exemplify remarkable levels of resilience and coping. Yet, research on resilience and coping in this population is limited. Twenty Black WLWH in the Southern United States completed semi-structured interviews that explored challenges facing WLWH. We identified six themes related to resilience and coping: self-acceptance, disclosure, self-compassion, social support, will to live, and service. Of these, social support was a driving protective element and an essential component to building and sustaining resilience and coping. Women who experienced positive support often expressed a will to live as well as a desire to support other WLWH. Resilience and social support were characterized by patterns of reciprocity, in that they were mutually sustaining, stabilizing, and strengthening

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

Introduction: We hypothesized that activating KRAS mutations and inactivation of the liver kinase B1 (LKB1) oncosuppressor can cooperate to sustain NSCLC aggressiveness. We also hypothesized that the growth advantage of KRAS/LKB1 co-mutated tumors could be balanced by higher sensitivity to metabolic stress conditions, such as metformin treatment, thus revealing new strategies to target this aggressive NSCLC subtype. Methods: We retrospectively determined the frequency and prognostic value of KRAS/LKB1 co-mutations in tissue specimens from NSCLC patients enrolled in the TAILOR trial. We generated stable LKB1 knockdown and LKB1-overexpressing isogenic H1299 and A549 cell variants, respectively, to test the in vitro efficacy of metformin. We also investigated the effect of metformin on cisplatin-resistant CD133+cells in NSCLC patient-derived xenografts. Results: We found a trend towards worse overall survival in patients with KRAS/LKB1 co-mutated tumors as compared to KRAS-mutated ones (hazard ratio: 2.02, 95% confidence interval: 0.94\u20134.35, p = 0.072). In preclinical experiments, metformin produced pro-apoptotic effects and enhanced cisplatin anticancer activity specifically in KRAS/LKB1 co-mutated patient-derived xenografts. Moreover, metformin prevented the development of acquired tumor resistance to 5 consecutive cycles of cisplatin treatment (75% response rate with metformin-cisplatin as compared to 0% response rate with cisplatin), while reducing CD133+cells. Conclusions: LKB1 mutations, especially when combined with KRAS mutations, may define a specific and more aggressive NSCLC subtype. Metformin synergizes with cisplatin against KRAS/LKB1 co-mutated tumors, and may prevent or delay the onset of resistance to cisplatin by targeting CD133+cancer stem cells. This study lays the foundations for combining metformin with standard platinum-based chemotherapy in the treatment of KRAS/LKB1 co-mutated NSCLC